首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4303830篇
  免费   350753篇
  国内免费   15330篇
耳鼻咽喉   61287篇
儿科学   133620篇
妇产科学   112163篇
基础医学   657713篇
口腔科学   119302篇
临床医学   390149篇
内科学   779818篇
皮肤病学   103754篇
神经病学   368822篇
特种医学   171238篇
外国民族医学   912篇
外科学   655787篇
综合类   126426篇
现状与发展   23篇
一般理论   2612篇
预防医学   364138篇
眼科学   101024篇
药学   303251篇
  25篇
中国医学   11385篇
肿瘤学   206464篇
  2021年   55852篇
  2020年   35574篇
  2019年   58721篇
  2018年   73460篇
  2017年   56126篇
  2016年   62454篇
  2015年   75671篇
  2014年   110480篇
  2013年   175886篇
  2012年   119642篇
  2011年   123018篇
  2010年   123514篇
  2009年   126461篇
  2008年   110015篇
  2007年   116742篇
  2006年   126066篇
  2005年   121243篇
  2004年   122140篇
  2003年   112822篇
  2002年   103292篇
  2001年   154353篇
  2000年   150496篇
  1999年   139578篇
  1998年   71331篇
  1997年   67800篇
  1996年   65684篇
  1995年   61523篇
  1994年   55595篇
  1993年   51632篇
  1992年   103588篇
  1991年   98963篇
  1990年   94068篇
  1989年   91701篇
  1988年   85325篇
  1987年   83782篇
  1986年   79477篇
  1985年   77932篇
  1984年   65958篇
  1983年   58868篇
  1982年   48158篇
  1981年   44895篇
  1980年   42181篇
  1979年   57836篇
  1978年   47037篇
  1977年   41603篇
  1976年   38655篇
  1975年   37848篇
  1974年   42426篇
  1973年   40559篇
  1972年   38022篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
191.
随着婴儿潮、人口老龄化及新技术的广泛应用,人们对听力保健的需求显著增加。在美国,听力保健服务由助听设备专员、耳鼻喉科医生和听力师3类人员提供,其中听力师提供除医疗、手术外宽泛的听力保健服务。美国的听力保健服务体系及听力师教育体系经历了一个渐进的过程:20年前对从业人员的学历要求是听力学硕士,随着对服务质量要求的提高和服务范围的扩大,美国听力师逐渐要求专业博士学位(Au.D),毕业后还需3~4年的专门教育才能成为一名听力师。听力师教育有统一的标准,大学课程要通过听力教育认证委员会(the Accreditation Commission for Audiology Education, ACAE)或学术认证委员会(the Council on Academic Accreditation,CAA)的多程序严格的认证才能被承认。美国听力师需求存在巨大缺口,但是各国听力学教育标准不统一及听力师收入与教育投资不匹配,阻碍了更多的人进入这一领域。美国试图通过改变教育模式,降低教育成本及革新教学方法等改善听力师教育状况,但是听力师教育体系远未完善。  相似文献   
192.
Obtaining accurate assessment data from adolescents in treatment aids clinical decision making and facilitates more accurate outcome evaluations. However, findings could be biased due to underreported substance use and mental health symptoms. This article compares self-reports of youth in non-White matched client–assessor dyads and those in nonmatched dyads. There were no differences on self-reported substance use, but matched youth reported significantly fewer attention deficit/hyperactivity disorder symptoms versus the comparison group. One possible reason for these findings is the effect of in-group stereotype threat. Future studies should examine the potential effect that in-group stereotyping and perceived racism have on the therapeutic relationship.  相似文献   
193.
194.
195.
196.
This study explored the relationship between active mediation, exposure to Daniel Tiger’s Neighborhood, and key indicators of preschoolers’ social and emotional development. One hundred and twenty-seven children aged 2–6 either watched or did not watch 10 episodes of Daniel Tiger’s Neighborhood over a two-week period. Results revealed that preschoolers who watched the program exhibited higher levels of empathy, self-efficacy, and emotion recognition when their regular TV-watching experiences are frequently accompanied by active mediation. This was especially true for younger preschoolers and preschoolers from low-income families. Implications for policy-makers, parents, producers of prosocial programming, and educators are discussed.  相似文献   
197.
198.
199.
On 8 April 2014, a US jury ordered Takeda and Eli Lilly to pay $9 bn in punitive damages after finding that they had concealed the cancer risks associated with pioglitazone. By contrast, on 28 August 2014, the long‐awaited outcome of the 10‐year Kaiser Permanente Northern California study was announced. That study was specifically designed to investigate whether patients exposed to pioglitazone were at an increased risk of bladder cancer and found no association; thus, at last, the controversial issue has been resolved. A review, in retrospect, of the story of the proposed link between pioglitazone and bladder cancer reveals flaws at every stage. In 2012, a BMJ editorial, in keeping with some other contemporary reports, stated ‘it can confidently be assumed that pioglitazone increases the risk of bladder cancer’. Examination of the information which led to such a statement shows that: 1) the pre‐clinical findings of bladder cancer in male rats is not indicative of human risk; 2) there is no association between bladder cancer and pioglitazone in randomized controlled trials, once cases that could not plausibly be related to treatment are removed; and 3) the observational studies that have suggested a link have over‐extrapolated from the data: pioglitazone‐treated patients had more risk factors for bladder cancer than those not treated with pioglitazone. Meanwhile careful study of randomized controlled trials shows evidence of cardiovascular benefit from pioglitazone in Type 2 diabetes, a condition which results, more than anything, in premature cardiovascular death and morbidity.  相似文献   
200.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号